W Xue

Cervical Cancer Hela Cell Osteopontin Gene Suppression Model and Detection

Issue:

Vol 65, Issue 4: 2016 – Health Science

DOI:

10.7727/wimj.2016.254

Pages:

608-12

Synopsis:

This research is to develop an osteopontin (OPN) specific siRNA expression vector and transfect it into cervical cancer Hela cells, in order to obtain OPN stable transfection cell lines, thus providing support for further study on the mechanism of OPN in cervical cancer Hela cells.

ABSTRACT

Objective: To build an osteopontin (OPN) specific short interfering ribonucleic acid (siRNA) expression vector and transfect it into cervical cancer Hela cells, in order to obtain OPN stable transfection cell lines, thus providing support to the further study on the mechanism of OPN in cervical cancer Hela cells.

Received:

07 Jun, 2016

Accepted:

22 Aug, 2016

Published:

09 Jul, 2018

PDF Attachment:

wimj-iss4-2016_608_612.pdf

Journal Sections:

Original Articles

Keywords:

Cervical cancer

osteopontin

ribonucleic acid interference

Journal Authors:

e-Published: 09 Jul, 2018

Read more about Cervical Cancer Hela Cell Osteopontin Gene Suppression Model and Detection

The Feasibility of Using Magnetic Nanoparticles Modified as Gene Vector

Issue:

Vol 59, issue 3 (2010)

Pages:

300–5

Synopsis:

Magnetic nanoparticles can be used as novel non-viral gene vector in vitro, which offers a basis for gene delivery in vivo.

ABSTRACT

Objective: To evaluate the feasibility of using magnetic nanoparticles (MNPs) as gene vector and the effect of magnetic field on efficiency of transfection.

PDF Attachment:

dr_chen.qxd_.pdf

Journal Sections:

Original Articles

Keywords:

Magnetic field

magnetic nanoparticles (MNPs)

Journal Authors: